Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

A new method for delivering radioactive cytotoxic agents in solid cancers

S E Order1, J A Siegel, R A Lustig

  • 1Department of Radiation Oncology, Cooper Hospital/University Medical Center, Camden, NJ 08103.

International Journal of Radiation Oncology, Biology, Physics
|October 15, 1994
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Search for violation of Lorentz invariance in top quark pair production and decay.

Physical review letters·2012
Same author

Combined search for the standard model Higgs boson decaying to bb using the D0 run II data set.

Physical review letters·2012
Same author

Search for the standard model Higgs boson in ZH→ℓ(+)ℓ(-)bb production with the D0 detector in 9.7 fb(-1) of pp collisions at √s = 1.96 TeV.

Physical review letters·2012
Same author

Cryptococcus neoformans-Cryptococcus gattii species complex: an international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for fluconazole, itraconazole, posaconazole, and voriconazole.

Antimicrobial agents and chemotherapy·2012
Same author

Role of occupational health staff in investigation of invasive group A streptococcal infection hospital outbreak.

The Journal of hospital infection·2012
Same author

Measurement of the W boson mass with the D0 detector.

Physical review letters·2012

A novel intratumoral infusion technique using macroaggregated albumin (MAA) enhances radioactive agent deposition in solid tumors for improved cancer therapy. This method ensures prolonged agent localization and increased therapeutic efficacy.

Area of Science:

  • Oncology
  • Nuclear Medicine
  • Biomedical Engineering

Background:

  • Current cancer therapeutics like monoclonal antibodies and radiopharmaceuticals face limitations in achieving sufficient concentration and duration within solid tumors.
  • Understanding solid tumor pathophysiology is key to developing strategies for enhanced therapeutic agent delivery and retention.

Purpose of the Study:

  • To introduce and evaluate a novel intratumoral infusion technique designed to improve the deposition and retention of therapeutic radioactive agents in solid tumors.
  • To enhance the effectiveness of cancer treatments by enabling prolonged interaction between therapeutic agents and tumor cells.

Main Methods:

  • The study investigated three agents: 131I antiferritin monoclonal antibody, colloidal 32P chromic phosphate, and 131I transferrin.

Related Experiment Videos

  • A new in vivo tumor infusion method involved direct intratumoral injection of macroaggregated albumin (MAA) followed by radioactive agents.
  • Experimental comparisons were made between the new technique and conventional intratumoral infusion or intraperitoneal administration.

    • Main Results:

    • Intratumoral injection of macroaggregated albumin (MAA) induced direct vascular blockade, significantly increasing the deposition of subsequently administered agents for at least 24 hours.
    • Clinical application of MAA followed by 32P colloidal chromic phosphate yielded results consistent with experimental findings.
    • The novel technique demonstrated superior retention of radioactive agents within tumors compared to control methods.

    Conclusions:

    • A new technique utilizing direct tumor infusion of macroaggregated albumin (MAA) followed by radioactive agents has been developed for experimental and clinical use.
    • This method facilitates sustained localization of agents within solid cancers, enabling high tumor dose deposition.
    • The technique holds potential for significantly increasing the therapeutic efficacy of radioactive cancer treatments.